Aberdeen Group plc Raises Position in DuPont de Nemours, Inc. $DD

Aberdeen Group plc raised its position in DuPont de Nemours, Inc. (NYSE:DD) by 6.5% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 495,419 shares of the basic materials company’s stock after buying an additional 30,189 shares during the quarter. Aberdeen Group plc owned about 0.12% of DuPont de Nemours worth $38,199,000 at the end of the most recent reporting period.

Other hedge funds have also bought and sold shares of the company. Norges Bank purchased a new position in DuPont de Nemours during the second quarter valued at $313,306,000. Ilex Capital Partners UK LLP boosted its stake in shares of DuPont de Nemours by 175.8% in the 2nd quarter. Ilex Capital Partners UK LLP now owns 2,043,299 shares of the basic materials company’s stock worth $140,150,000 after buying an additional 1,302,341 shares during the last quarter. AQR Capital Management LLC grew its stake in shares of DuPont de Nemours by 139.3% during the 2nd quarter. AQR Capital Management LLC now owns 1,791,511 shares of the basic materials company’s stock valued at $122,486,000 after purchasing an additional 1,042,929 shares during the period. Holocene Advisors LP grew its position in DuPont de Nemours by 70.5% during the second quarter. Holocene Advisors LP now owns 2,398,287 shares of the basic materials company’s stock valued at $164,499,000 after buying an additional 991,985 shares during the period. Finally, Boston Partners increased its stake in shares of DuPont de Nemours by 36.6% in the 2nd quarter. Boston Partners now owns 3,483,001 shares of the basic materials company’s stock worth $238,924,000 after purchasing an additional 932,575 shares in the last quarter. 73.96% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of analysts have recently issued reports on DD shares. BMO Capital Markets increased their price objective on shares of DuPont de Nemours from $50.00 to $60.00 and gave the stock an “outperform” rating in a research note on Thursday, February 12th. Mizuho raised their price target on DuPont de Nemours from $46.00 to $52.00 and gave the stock an “outperform” rating in a research report on Tuesday, February 10th. Argus dropped their target price on DuPont de Nemours from $86.00 to $52.00 and set a “buy” rating for the company in a research report on Thursday, February 5th. Deutsche Bank Aktiengesellschaft cut their price target on shares of DuPont de Nemours from $90.00 to $46.00 and set a “buy” rating on the stock in a report on Tuesday, November 25th. Finally, Jefferies Financial Group raised their price objective on DuPont de Nemours from $51.00 to $59.00 and gave the stock a “buy” rating in a report on Wednesday, February 11th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, three have given a Hold rating and one has given a Sell rating to the company. Based on data from MarketBeat, DuPont de Nemours has a consensus rating of “Moderate Buy” and an average price target of $50.46.

Insider Buying and Selling

In other DuPont de Nemours news, CEO Lori Koch sold 9,011 shares of the business’s stock in a transaction that occurred on Friday, November 28th. The stock was sold at an average price of $39.46, for a total transaction of $355,574.06. Following the transaction, the chief executive officer owned 288,326 shares of the company’s stock, valued at $11,377,343.96. The trade was a 3.03% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Erik T. Hoover sold 6,005 shares of the company’s stock in a transaction that occurred on Friday, November 28th. The shares were sold at an average price of $39.79, for a total value of $238,938.95. Following the completion of the transaction, the senior vice president directly owned 112,101 shares in the company, valued at $4,460,498.79. The trade was a 5.08% decrease in their position. The SEC filing for this sale provides additional information. Corporate insiders own 0.61% of the company’s stock.

DuPont de Nemours Trading Up 1.5%

DD opened at $50.19 on Tuesday. The company has a current ratio of 2.42, a quick ratio of 1.91 and a debt-to-equity ratio of 0.22. The stock has a market capitalization of $21.03 billion, a P/E ratio of -26.98, a P/E/G ratio of 1.26 and a beta of 1.10. The firm’s fifty day simple moving average is $43.48 and its 200 day simple moving average is $37.44. DuPont de Nemours, Inc. has a 12 month low of $22.50 and a 12 month high of $52.66.

DuPont de Nemours (NYSE:DD) last announced its earnings results on Tuesday, February 10th. The basic materials company reported $0.46 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.43 by $0.03. DuPont de Nemours had a positive return on equity of 7.37% and a negative net margin of 7.03%.The business had revenue of $1.69 billion for the quarter, compared to analyst estimates of $1.69 billion. During the same quarter last year, the firm earned $1.13 EPS. DuPont de Nemours’s revenue for the quarter was up .2% compared to the same quarter last year. DuPont de Nemours has set its FY 2026 guidance at 2.250-2.300 EPS and its Q1 2026 guidance at 0.480-0.480 EPS. As a group, research analysts anticipate that DuPont de Nemours, Inc. will post 4.38 EPS for the current fiscal year.

DuPont de Nemours announced that its board has initiated a stock repurchase plan on Thursday, November 6th that allows the company to repurchase $2.00 billion in shares. This repurchase authorization allows the basic materials company to reacquire up to 12.2% of its shares through open market purchases. Shares repurchase plans are often an indication that the company’s management believes its stock is undervalued.

DuPont de Nemours Profile

DuPont de Nemours (NYSE: DD) is a global science and engineering company that develops and supplies specialty materials, chemicals and industrial biosciences for a wide range of markets. Headquartered in Wilmington, Delaware, the company traces its origins to 1802 and has evolved through more than two centuries of innovation. In recent history DuPont participated in a major combination with Dow Chemical and subsequent reorganization that refocused the company on differentiated, specialty businesses built around science-based solutions.

DuPont’s operations center on advanced materials and technologies used by manufacturers and OEMs in industries such as transportation, electronics, construction, industrial manufacturing and worker safety.